Clinical Trial Update: EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment

View source ↗

Summary

A terminated clinical trial evaluating certolizumab pegol (Cimzia) for perianal and peri-rectal fistulizing Crohn's disease, using endoscopic ultrasound evaluat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Crohns Disease | Status: TERMINATED